A method for forming an anti-thrombotic conjugate material comprises:providing at least one cyclic lactone molecule,forming a bioabsorbable co-polymer using PVA as an initiator in a ring opening polymerization of the at least one cyclic lactone molecule, andextending the bioabsorbable co-polymer with a dicarboxylic anhydride and a heparin sequentially.